COO and President of Rocket Pharmaceuticals, Kinnari Patel’s, shares how the company is using gene therapy to eradicate diseases in children.
Kinnari Patel’s love for science began at a very young age as her traditional Indian parents may have strongly encouraged – or rather expected her to like science – it didn't take much convincing for her to follow her natural curiosity. That curiosity led Patel to the C-Suite at cutting edge biotech companybefore the age of 40. Fast forward to today Patel is leading the way in finding gene therapy treatments for rare diseases in children.
“Science was often seen as a path to success and in a field highly respected, which I fully appreciate now,” Patel explained. “As an undergraduate, I pursued a pre-med curriculum and enjoyed pharmacy courses, especially in how drugs were created, interacted with each other and impacted patients.
Despite some of the major barriers in the industry, Patel saw a huge opportunity to apply her big pharma experience in a new visionary biotech company and potentially change the trajectory of people’s lives and for generations to come.
Like most women she knew, Patel had also experienced gender discrimination in her past roles. From ideas being blatantly ignored by male colleagues to receiving feedback about her appearance. “In the beginning of my career, I went along with some of these suggestions regarding my appearance – I wore glasses to appear older, dressed formally, and smiled less,” Patel said.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Biotech Leader Shares How Rocket Pharmaceuticals Is Working To Eradicate Rare Diseases In ChildrenCOO and President of Rocket Pharmaceuticals, Kinnari Patel’s, shares how the company is using gene therapy to eradicate diseases in children.
Leer más »
Roche's head of pharmaceuticals to leave companyRoche said on Monday the head of its pharmaceuticals division had decided to leave after 16 years with the Swiss drugmaker, heralding a wider reshuffle in addition to a planned CEO changeover early next year.
Leer más »
Amgen set to buy biotech firm Horizon at $26 bln valuation - Bloomberg NewsAmgen Inc is set to buy biotech firm Horizon Therapeutics Plc at a valuation of about $26 billion in what would be its largest acquisition, Bloomberg News reported on Monday.
Leer más »
NASA rocket launch on Tuesday may be visible from N.J., N.Y. and Pa.After a weather delay, the rocket is now scheduled to lift off Tuesday from the NASA Wallops Flight Facility in Virginia.
Leer más »
Artemis I Orion capsule set for splashdown after NASA mission near moonThe Artemis I Orion capsule is set to splash down on Sunday after a 25-day trip that reached within 60 miles of the moon, completing the first step in an ambitious plan to establish a long-term presence there and later send a crewed shuttle to Mars.
Leer más »
Watch live: Artemis I moon rocket to splashdown in Pacific Ocean following historic mission SundayThe Artemis 1 test flight ends Sunday when Orion splashes down in the Pacific Ocean. NASA's spacecraft designed to carry humans back to the moon is in the final stages of a 25.5 moon-orbiting mission.
Leer más »